Abstract
BackgroundChimeric antigen receptor T-cell (CART) and engineered T-cell receptor cytotoxic T cell (TCRT) therapy are adoptive cellular therapies developed by modifying T-cells to target surface antigens of cancer cells in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have